Article Text

Download PDFPDF

Spontaneous reversion of paroxysmal atrial fibrillation detected by smart watch
Free
  1. Liam Toner1,2,
  2. Ahmed M Al-Kaisey1,
  3. Anoop Koshy1 and
  4. Han Sung Lim1,2
  1. 1Department of Cardiology, Austin Hospital, Melbourne, Victoria, Australia
  2. 2Department of Cardiology, The Northern Hospital, Melbourne, Victoria, Australia
  1. Correspondence to Dr Liam Toner; liam.toner{at}nh.org.au

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Description

Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with heart failure, cardioembolic stroke and increased overall mortality.1 Periodic 24 hours Holter monitoring is traditionally used to assess adequacy of rate control and direct titration of medical therapy. With the growth of smart watches that estimate heart rate (HR), there is increasing interest regarding the utility of these devices for chronotropic assessment and arrhythmia detection.2 Smart watches continuously estimate heart rate using optical detection of photoplethysmographic signals from infrared light emitting diodes where each pulsatile signal corresponds to a heartbeat.3

We present the case of a patient with known AF whose spontaneous reversion to sinus rhythm (SR) was detected as a sudden and persistent decrease in HR as measured by their smart watch and confirmed by a concurrently fitted Holter monitor.

An 80-year-old woman with a known history of paroxysmal atrial fibrillation underwent routine ambulatory Holter monitoring to assess the adequacy of ventricular rate control. On returning the Holter monitor the next day, she reported the sensation of her heart ‘doing a flip’ at 19:29 as she noted her heart rate suddenly drop from 99 bpm to 65 bpm as measured by her Apple Watch Series 3 (Cupertino, USA). Review of the Holter monitor revealed she had reverted from AF to SR at that time, figure 1. The heart rate recordings from the Apple Watch were extracted and synchronised to the Apple Health App (Cupertino, USA) and then exported to Microsoft Excel. A total of 199 heart rate readings were recorded from the Apple Watch and matched to 199 readings of the same time intervals on Holter monitoring over a 22-hour period as shown in figure 2 (median interval 6 min and IQR of 5.75 min). Moreover, the average HR as measured by smart watch in AF prior to reversion was 94 bpm compared with 66 bpm after reversion to SR.

Figure 1

Heart rate versus time as recorded by the smart Watch (red) and Holter monitor (blue). reversion from atrial fibrillation to sinus rhythm occurred at 19:29.

Figure 2

Rhythm strip as recorded by the Holter monitor at 19:29 demonstrating atrial fibrillation (green) followed by two junctional beats then reversion to sinus rhythm.

Our key finding is that a sudden and persistent alteration in HR on a wearable device may be suggestive of a subclinical arrhythmia. This case highlights the advantage of incorporating continuous capture photoplethysmography with contemporary single-lead ECG technology to facilitate chronotropic and rhythm assessment of patients with atrial fibrillation.

Learning points

  • Sudden and persistent changes in heart rate as detected by smart watches should alert clinicians to the possibility of cardiac rhythm changes.

  • The patient outcomes and management of arrhythmias detected by smart watch heart rate monitoring are the subject of ongoing research.

References

Footnotes

  • Contributors All authors have contributed to the manuscript and have approved a final version of the manuscript. LT—data analysis, manuscript preparation. AMAK—data analysis, manuscript preparation and editing. AK—data analysis, manuscript preparation and editing. HSL—planning, conception and manuscript editing.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.